Expert-Backed CGMs for Healthy Adults Reveal Glucose Insights With Evidence Gaps
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
56 articles
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
New expert reviews compare NMN and NR head-to-head, ranking top products by purity, absorption, and clinical evidence.
Expert reviews compare leading NMN and NR supplements on clinical evidence, purity, and value โ with key caveats on what the science can and cannot yet prove.
A landmark review maps the vaginal microbiome's role in infections and reproductive health, charting a path to precision probiotic therapies.
A rigorous product review reveals major quality gaps in NAD+ supplements and what dosing evidence actually supports.
A Cochrane review of two RCTs finds very low-certainty evidence that IGF-1 neither prevents nor worsens retinopathy of prematurity in extremely preterm infants.
A Cochrane review of 4 RCTs finds no reliable evidence that adding endovascular stenting to medical therapy prevents stroke or death in vertebral artery stenosis.
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
Longevity experts endorse CGMs for metabolic optimization, but RCT evidence in non-diabetics is still thin.
A head-to-head comparison of NMN and NR supplements reveals distinct benefit profiles โ and major quality gaps across popular brands.
Bacteriophages transferred during FMT may drive horizontal gene transfer, altering microbial function and antibiotic resistance in ways science has largely ignored.
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.